GlassScriptPhysician profile
Alexander Michael Schwartz
NPI 1275569378
$1,634.83
in general payments reported to CMS, 2019-2025
22 companies · $624 in 2025
The $624 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.74 · 2021: $15.58 · 2022: $435 · 2023: $17.00 · 2024: $529 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $341.75 | 2024-2025 | Gemtesa, Orgovyx |
| Medtronic, INC. | $192.60 | 2022-2024 | Minimed 780g |
| Urogen Pharma, INC. | $136.27 | 2025 | |
| Novo Nordisk INC | $124.51 | 2022 | |
| Janssen Biotech, INC. | $99.64 | 2022-2025 | Erleada, Akeega |
| Teleflex LLC | $97.83 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.62 | 2024-2025 | |
| Tolmar, INC. | $70.17 | 2024-2025 | Eligard, Jatenzo |
| Asensus Surgical, INC. | $63.84 | 2022 | |
| Pfizer INC. | $61.53 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $57.15 | 2025 | |
| Progenics Pharmaceuticals, INC. | $51.81 | 2025 | |
| Myriad Genetic Laboratories, INC. | $48.85 | 2024-2025 | Prolaris |
| Endo USA, INC. | $43.76 | 2024-2025 | Xiaflex |
| Procept Biorobotics Corporation | $37.39 | 2024 | Aquabeam System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $21.59 | 2025 | |
| Astellas Pharma US INC | $18.60 | 2025 | Xtandi |
| Glaxosmithkline, LLC. | $17.00 | 2023 | Shingrix |
| Verity Pharmaceuticals INC. | $14.89 | 2025 | Trelstar |
| Boston Scientific Corporation | $14.74 | 2020 | |
| Amarin Pharma, INC. | $14.16 | 2022 | |
| Accord Healthcare, INC. | $13.13 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.